eLabNext and BU’s DAMP Lab partner to launch 'DAMP Lab Canvas,' a platform to streamline molecular biology service ordering, announced at the 2024 BioManufacturing Automation Workshop. The Design, Automation, Manufacturing, and Processes (DAMP) Lab and eLabNext announced a formal partnership today to coincide with the kick-off of the International Workshop for BioManufacturing Automation 2024 at Boston University (BU). The [...]

New England Biolabs Lyophilization Sciences® further strengthens its ability to deliver a best-in-class solution for customers in need of lyophilized products IPSWICH, Mass. -- New England Biolabs (NEB®), a leading supplier of life science reagents, announced the opening of its first manufacturing facility outside of the United States. New England Biolabs Lyophilization Sciences (NEB Lyo Sciences®) joins NEB's [...]

SUWON, South Korea -- Park Systems (CEO Dr. Sang-il Park), a leading provider of nanometrology solutions with Atomic Force Microscopy (AFM) and Imaging Spectroscopic Ellipsometry (ISE), is proud to announce a new partnership with Labindia Instruments Pvt. Ltd. for business expansion in India. (Left to Right) Representatives from Labindia Instruments Pvt. Ltd. and Park Systems gather for the [...]

New Technology Expands Antibody Compatibility and Doubles Throughput while maintaining Tissue Integrity and Lack of Cross-Reactivity BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced a major technological breakthrough in the CellScape™ Precise Spatial Proteomics platform for highly multiplexed immunofluorescence (IF). Launched in 2022, the CellScape platform has advanced the field of spatial proteomics with differentiated quantitative performance [...]

SHANGHAI -- Illumina Hong Kong LIMITED (Illumina), a global leader in DNA sequencing and array-based technologies, and PHASE Scientific International Limited (PHASE), a Hong Kong-based biotech company with operations in the U.S. and the Greater Bay Area (GBA), signed a three-year Memorandum of Understanding (MoU) on 7 November at the 7th China International Import Expo. The two [...]

News Summary: waters_connect™ Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation. Cloud-based software proactively provides visibility into risks that could trigger adverse regulatory findings, delivering seamless remote data access, comprehensive analytics, [...]

SOUTH SAN FRANCISCO, Calif. -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced the appointment of Alex Kim as Chief Financial Officer, effective November 11, 2024. Kim, a co-founder and most recently Chief Operating Officer of Standard BioTools, brings nearly 30 years of financial and operations experience in the healthcare and [...]

Shenzhen, China – MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced a commercial partnership with Human Cell Atlas (HCA) consortium to further accelerate the human cell mapping initiative. Aimed to facilitate the wider adoption of single cell sequencing and spatial transcriptomics technologies globally, [...]

ST. LOUIS -- Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, in conjunction with its portfolio company, Savillex, today announced the acquisition of Optimum Processing, Inc. (Optimum Processing). The addition of Optimum Processing, a manufacturer of customized, single-use bioprocessing systems for life science use cases, positions Savillex as a leader in providing [...]

Wales is edging closer to being at the forefront of genomics after the NHS signed an ambitious new collaboration with a leading science technology company. The memorandum of understanding (MoU) between the NHS in Wales and Illumina will build on existing research into lung cancer diagnostics, with the ambition to further expand into other cancer [...]